Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Value-Based Purchasing Measures Should Be Publicly Vetted, CMS Told

This article was originally published in The Gray Sheet

Executive Summary

CMS should open a public comment period for any new quality measures it plans to include in Medicare's hospital value-based purchasing program, a divergent group of stakeholders is advising the agency.

You may also be interested in...



Quality Measures To Play Key Role In Payment Reform, Former CMS Official Says

An official with the National Quality Forum explains how matching the right quality measure to each new Medicare payment model will be critical to preventing unintended consequences such as reduced care for patients.

Quality Measures To Play Key Role In Payment Reform, Former CMS Official Says

An official with the National Quality Forum explains how matching the right quality measure to each new Medicare payment model will be critical to preventing unintended consequences such as reduced care for patients.

Industry Wins Some, Loses Some In Final Value-Based Purchasing Rule

The device industry was able to wring some concessions from CMS in a new hospital inpatient value-based purchasing rule issued April 29, but the Medicare agency declined to make any special provisions for additional resources that hospitals may need to purchase newer medical technologies.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029946

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel